NCT04713306

Brief Summary

BACKGROUND: The complex impact of gender has been studied in different perspectives of health and disease in the literature. However, few attempts have been made to compile data from systematic disease specific registrations Swedish National Quality Registers play an important role in collecting large amounts of diagnose specific data, symptoms, and treatments. The subset Parkinson Registry has been in use for more than 20 years and are represented in all counties and hospitals where neurological care is provided in Sweden and offer optimal conditions to describe gender specific differences in the use of diagnostic tools, lead times and symptom profiles.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,217

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
13.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

October 6, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 19, 2021

Completed
Last Updated

March 30, 2021

Status Verified

March 1, 2021

Enrollment Period

13.3 years

First QC Date

October 6, 2020

Last Update Submit

March 29, 2021

Conditions

Parkinson Disease

Keywords

NonMotorSymptoms, medication, National Registries

Outcome Measures

Primary Outcomes (1)

  • Differences between gender

    investigations, medications,NonMotorSymptoms

    2006-2020

Study Arms (1)

Participants in the Swedish Neuro Register

Participants are patients with parkinsonian symptoms

Eligibility Criteria

Age1 Year - 100 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailsyes self-representation
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Cohorts from rural areas and larger cities of Southern Sweden with diagnosed parkinsonism.

You may qualify if:

  • Participants registered in the Swedish Neuro Registers.
  • Parkinson´s Disease
  • Acceptance of extraction of data

You may not qualify if:

  • non parkinsonian patients
  • Participants in the Registries who have not given allowance of extraction of data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FUTURUM

Jönköping, SE 551 85, Sweden

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Johan Lokk, PhD

    Karolinska Institutet

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
14 Years
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2020

First Posted

January 19, 2021

Study Start

January 1, 2006

Primary Completion

May 1, 2019

Study Completion

December 31, 2019

Last Updated

March 30, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations

SE(1)